Rebar Interactive founder Rahlyn Gossen was quoted in an Outsourcing Pharma article titled “How Prevalent is Dual Enrollment in Clinical Trials? Opinion Split.” The article discusses the prevalence of dual enrollment, as well as the clinical trial complications that can arise from it.
Leave a Reply